%0 Journal Article %1 Osipenko2024 %A Osipenko, Leeza %A Potey, Philippe %A Perez, Bernardo %A Kupryjanczuk, Alexandra %A Angelov, Filip %A Schuster, Alexandra %A Mossialos, Elias %D 2023 %I American Medical Association (AMA) %K ClinicalBenefit DrugDevelopment marketing %N 1 %P 46 %R 10.1001/jamainternmed.2023.6249 %T Provenance and Clinical Benefit of Medicines Introduced to the French Market, 2008 to 2018 %V 184

@article{Osipenko2024, added-at = {2024-01-04T11:18:37.000+0100}, author = {Osipenko, Leeza and Potey, Philippe and Perez, Bernardo and Kupryjanczuk, Alexandra and Angelov, Filip and Schuster, Alexandra and Mossialos, Elias}, biburl = {https://www.bibsonomy.org/bibtex/2acdaef19ff54194d7243b7c618d41940/jepcastel}, doi = {10.1001/jamainternmed.2023.6249}, interhash = {d57453781943230d95641e515c7469f3}, intrahash = {acdaef19ff54194d7243b7c618d41940}, issn = {2168-6106}, journaltitle = {JAMA Internal Medicine}, keywords = {ClinicalBenefit DrugDevelopment marketing}, number = 1, pages = 46, publisher = {American Medical Association (AMA)}, timestamp = {2024-01-04T11:18:37.000+0100}, title = {Provenance and Clinical Benefit of Medicines Introduced to the French Market, 2008 to 2018}, volume = 184, year = 2023 }